| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
296,250,000 |
| Market
Cap: |
561.39(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.86 - $4.49 |
|
| Level
I Sector: |
Energy |
| Level
II Sector: |
Energy |
| Level
III Sector: |
Independent Oil & Gas |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support the lifespan of women from pregnancy prevention through menopause. Co.'s solutions range from contraceptive to bio-identical hormone therapy pharmaceutical products for the treatment of vasomotor symptoms and dyspareunia. Co.'s contraceptive product consist of ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) a reversible prescription contraceptive that can prevent pregnancy. Co.'s menopause portfolio includes IMVEXXY (estradiol vaginal inserts) for the treatment of dyspareunia; and BIJUVA (estradiol and progesterone) capsules for the treatment of vasomotor symptoms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
711,818 |
| Total Buy Value |
$0 |
$0 |
$0 |
$29,673,332 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
9 |
| Total Shares Sold |
0 |
19,050 |
19,050 |
60,493 |
| Total Sell Value |
$0 |
$43,683 |
$43,683 |
$38,762,036 |
| Total People Sold |
0 |
1 |
1 |
6 |
| Total Sell Transactions |
0 |
2 |
2 |
15 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Donegan Michael C |
CAO and VP of Finance |
• – – |
2021-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
115,000 |
129,158 |
|
- |
|
| Collins Cooper C. |
Director |
– • – |
2021-11-18 |
4 |
B |
$0.58 |
$578,500 |
D/D |
1,000,000 |
2,236,864 |
2.39 |
-35% |
|
| Collins Cooper C. |
Director |
– • – |
2021-08-18 |
4 |
B |
$0.72 |
$648,000 |
D/D |
900,000 |
1,236,864 |
2.39 |
-49% |
|
| Collins Cooper C. |
Director |
– • – |
2021-08-17 |
4 |
B |
$0.77 |
$77,000 |
D/D |
100,000 |
336,864 |
2.39 |
-48% |
|
| Ling Karen |
Director |
– • – |
2021-08-17 |
4 |
B |
$0.75 |
$25,084 |
D/D |
33,445 |
130,309 |
2.39 |
-48% |
|
| Bisaro Paul |
Director |
– • – |
2021-08-16 |
4 |
B |
$0.79 |
$39,500 |
D/D |
50,000 |
196,864 |
2.39 |
-49% |
|
| Thompson Tommy G |
Director |
– • – |
2021-08-13 |
4 |
B |
$0.87 |
$9,570 |
I/I |
11,000 |
715,600 |
2.1 |
-53% |
|
| Darecca James |
Chief Financial Officer |
• – – |
2021-08-12 |
4 |
S |
$0.87 |
$81,203 |
D/D |
(93,337) |
123,830 |
|
53% |
|
| Naughton Gail K |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
96,864 |
|
- |
|
| Collins Cooper C. |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
236,864 |
|
- |
|
| Carroll J Martin |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
106,864 |
|
- |
|
| Bisaro Paul |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
146,864 |
|
- |
|
| Musing Jules A. |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
101,864 |
|
- |
|
| Thompson Tommy G |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
145,296 |
148,851 |
|
- |
|
| Russell Angus C. |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
190,364 |
|
- |
|
| Darecca James |
Chief Financial Officer |
• – – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
217,167 |
217,167 |
|
- |
|
| Ling Karen |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
96,864 |
|
- |
|
| Thompson Tommy G |
Director |
– • – |
2021-05-14 |
4 |
B |
$1.06 |
$5,300 |
I/I |
5,000 |
704,600 |
2.1 |
-32% |
|
| Donegan Michael C |
CAO and VP Finance |
• – – |
2021-05-11 |
4 |
S |
$1.04 |
$5,036 |
D/D |
(4,842) |
14,158 |
|
35% |
|
| Milligan John C.k. Iv |
Secretary/CEO of subsidiary |
• – – |
2021-05-11 |
4 |
S |
$1.04 |
$46,022 |
D/D |
(44,252) |
1,752,703 |
|
35% |
|
| Walker Marlan D |
General Counsel |
• – – |
2021-05-11 |
4 |
S |
$1.04 |
$22,456 |
D/D |
(21,592) |
28,908 |
|
35% |
|
| Borkowski Edward |
EVP, Operations |
• – – |
2021-05-11 |
4 |
S |
$1.04 |
$46,022 |
D/D |
(44,252) |
59,248 |
|
35% |
|
| Finizio Robert G |
CEO |
• • – |
2021-05-11 |
4 |
S |
$1.04 |
$70,405 |
D/D |
(67,697) |
17,991,637 |
|
35% |
|
| Donegan Michael C |
CAO and VP Finance |
• – – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,000 |
19,000 |
|
- |
|
| Milligan John C.k. Iv |
Secretary/CEO of subsidiary |
• – – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
103,500 |
1,796,955 |
|
- |
|
247 Records found
|
|
Page 3 of 10 |
|
|
0.01 (0.53%) 
